BERBERINE PREMIUM
Food supplement declared in France, declaration No 2022-10-353, decision dated 7 October 2022
BERBERINE PREMIUM (ENEFIS) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- ENEFIS
- Food business operator placing the product on the market
- BioUltime
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 3 gélules
- Directions for use
- 3 gélules par jour à avaler avec un grand verre d'eau
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Problèmes cardiaques, Sous traitement médicamenteux, Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)
- Flavourings
- /
Declaration 188463, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Berberis aristata DC. | Racine | Extrait sec aqueux | 550.005 mg |
| Vitis vinifera L. | Graine | Extrait sec aqueux | 139.701 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Protéine de pois | not declared |
Additives
E322
Other ingredients
Gélule végétale
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
Déconseillé aux femmes enceintes ou allaitantes, aux enfants, aux adolescents, aux personnes diabétiques, aux personnes présentant des troubles hépatiques ou cardiaques et aux personnes sous traitements médicamenteux.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- BERBERINE PREMIUM ENEFIS, declared in 2022, withdrawn from the market : same declared composition
Brand : ENEFIS